Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review

Frontiers in Microbiology
Martina RossittoPaola Rosati

Abstract

Although early aggressive and prolonged treatment with specific antibiotics can extend survival in patients with cystic fibrosis (CF) colonized by opportunistic Pseudomonas aeruginosa (PA), antibiotics fail to eradicate the infecting multidrug-resistant (MDR) PA strains in CF. Century-long research has suggested treating patients with bacteriophages (phages, prokaryotic viruses) naturally hosted by bacteria. Although the only phage types used in therapy, lytic phages, lyse PA aggregated in biofilm matrix by depolymerase degrading enzymes, how they can effectively, safely, and persistently do so in patients with CF is unclear. Even though advanced techniques for formulating phage cocktails, training phages and collecting phage libraries have improved efficacy in vitro, whether personalized or ready-to-use therapeutic approaches or phages and antibiotics combined are effective and safe in vivo, and can reduce PA biofilms, remains debatable. Hence, to advance clinical research on phage therapy in clinical trials, also involving mucoid and non-mucoid multidrug-resistant PA in CF, and overcome problems in Western international regulations, we need reliable and repeatable information from experiments in vitro and in vivo on phage cha...Continue Reading

References

Sep 1, 1989·Journal of General Microbiology·K J DaviesL Boddy
Sep 1, 1968·The Journal of General Virology·D E Bradley, D Robertson
Jan 19, 1999·Advances in Virus Research·H W Ackermann
May 21, 1999·Science·J W CostertonE P Greenberg
Apr 4, 2000·Microbiology·K D XuP S Stewart
Oct 12, 2000·Microbial Ecology·M Middelboe
Feb 13, 2001·Trends in Microbiology·T F Mah, G A O'Toole
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·A SulakvelidzeJ G Morris
Apr 5, 2002·Clinical Microbiology Reviews·Rodney M Donlan, J William Costerton
May 31, 2003·Nature Reviews. Drug Discovery·Carl R MerrilSankar L Adhya
Oct 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Algirdas J JesaitisZbigniew Lewandowski
Oct 14, 2003·American Journal of Respiratory and Critical Care Medicine·Ronald L GibsonBonnie W Ramsey
Jan 6, 2004·Nature Biotechnology·Karl Thiel
Sep 24, 2004·Luminescence : the Journal of Biological and Chemical Luminescence·Paola C BattánInés Albesa
Oct 16, 2004·Expert Review of Anti-infective Therapy·Sang Sun Yoon, Daniel J Hassett
Nov 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Blaise R BolesPradeep K Singh
Feb 3, 2005·JAMA : the Journal of the American Medical Association·Zhanhai LiMark L Splaingard
May 24, 2005·Infection and Immunity·Travis S WalkerJerry A Nick
Jun 3, 2005·Respiratory Research·Geraint B RogersKenneth D Bruce
Feb 3, 2006·Journal of Bacteriology·S FurukawaG A O'Toole
May 12, 2006·Proceedings of the National Academy of Sciences of the United States of America·Eric E SmithMaynard V Olson
Jan 17, 2007·Current Opinion in Pediatrics·Thomas S MurrayBarbara I Kazmierczak
Apr 10, 2007·Current Opinion in Pharmacology·Marisa I Gómez, Alice Prince
Jun 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·Timothy K Lu, James J Collins
Oct 12, 2007·Future Microbiology·Gilbert VerbekenJean-Paul Pirnay
Feb 1, 2008·Pulmonary Pharmacology & Therapeutics·Sophie Moreau-MarquisGeorge A O'Toole
Aug 12, 2008·Current Pharmaceutical Biotechnology·J Azeredo, I W Sutherland
Dec 11, 2008·Methods in Molecular Biology·Stephen T Abedon, John Yin
Dec 11, 2008·Methods in Molecular Biology·Thomas E WaddellRoger P Johnson
Feb 27, 2009·FEMS Microbiology Reviews·W James Gooderham, Robert E W Hancock
Apr 4, 2009·International Journal of Antimicrobial Agents·Ursula Theuretzbacher
Aug 14, 2009·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·A WrightD R Harper
Dec 17, 2009·The Journal of Infectious Diseases·Lisa A CarmodyJohn J LiPuma
Mar 4, 2010·The Journal of Infectious Diseases·Laurent DebarbieuxLhousseine Touqui
Mar 30, 2010·Nature Reviews. Microbiology·Simon J LabrieSylvain Moineau
Aug 10, 2010·Paediatric Respiratory Reviews·Bridget StuartPeter J Mogayzel

❮ Previous
Next ❯

Citations

Oct 12, 2018·Medical Sciences : Open Access Journal·Armelle PauleMarvin Edeas
Nov 15, 2019·Upsala Journal of Medical Sciences·Anders S Nilsson
Aug 4, 2020·Expert Opinion on Investigational Drugs·Ranjani SomayajiScott C Bell
Oct 28, 2019·Nature·Ellinor O AlsethEdze R Westra
Dec 31, 2019·Phytotherapy Research : PTR·Lijun WangGuixing Ren
Mar 11, 2020·Scientific Reports·Sangeeta BanerjiAntje Flieger
Jul 7, 2020·PHAGE : Therapy, Applications, and Research·Elizabeth B BurgenerPaul L Bollyky
Dec 14, 2018·Frontiers in Pharmacology·Stephanie TrendUNKNOWN AREST CF
Nov 9, 2018·Frontiers in Cellular and Infection Microbiology·Lucy L FurfaroBarbara J Chang
Sep 4, 2020·Expert Opinion on Drug Discovery·Xiaolong ShaoXin Deng
Jul 3, 2021·Antibiotics·Antonio Broncano-LavadoMeritxell García-Quintanilla
Oct 1, 2021·Scientific Reports·Sonika SharmaSanjai K Dwivedi

❮ Previous
Next ❯

Methods Mentioned

BETA
bronchoalveolar lavage
medical procedure

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.